{"id":3458,"date":"2023-12-04T17:58:16","date_gmt":"2023-12-04T16:58:16","guid":{"rendered":"https:\/\/cerenef.org\/?p=3458"},"modified":"2023-12-07T12:46:04","modified_gmt":"2023-12-07T11:46:04","slug":"jdp-2023","status":"publish","type":"post","link":"https:\/\/cerenef.org\/en\/jdp-2023\/","title":{"rendered":"JDP 2023"},"content":{"rendered":"<p><img decoding=\"async\" class=\"aligncenter wp-image-3457 size-full\" src=\"https:\/\/cerenef.org\/wp-content\/uploads\/2023\/12\/JDP-cerenef.png\" alt=\"JDP 2023\" width=\"800\" height=\"auto\" srcset=\"https:\/\/cerenef.org\/wp-content\/uploads\/2023\/12\/JDP-cerenef.png 1500w, https:\/\/cerenef.org\/wp-content\/uploads\/2023\/12\/JDP-cerenef-300x100.png 300w, https:\/\/cerenef.org\/wp-content\/uploads\/2023\/12\/JDP-cerenef-1024x341.png 1024w, https:\/\/cerenef.org\/wp-content\/uploads\/2023\/12\/JDP-cerenef-768x256.png 768w, https:\/\/cerenef.org\/wp-content\/uploads\/2023\/12\/JDP-cerenef-18x6.png 18w\" sizes=\"(max-width: 1500px) 100vw, 1500px\" \/><\/p>\n<p>L&rsquo;\u00e9quipe du centre CERENEF, Centre de R\u00e9f\u00e9rence des Neurofibromatoses sera pr\u00e9sente aux Journ\u00e9es Dermatologiques de Paris (JDP) 2023 qui se d\u00e9rouleront du 05 au 09 d\u00e9cembre au Palais des Congr\u00e8s de Paris !<\/p>\n<p><strong>4 communications orales seront pr\u00e9sent\u00e9es<\/strong> par Laura Fertitta et Laura Mengeot lors de la session \u00ab\u00a0G\u00e9n\u00e9tique et g\u00e9nodermatoses\u00a0\u00bb, le mercredi 06 d\u00e9cembre :<\/p>\n<p><span style=\"text-decoration: underline;\">Laura Fertitta :<\/span><\/p>\n<ul>\n<li>Mortalit\u00e9 chez les patients atteints de neurofibromatose de type 1 porteurs de neurofibromes sous-cutan\u00e9s : une \u00e9tude cas \u2013 t\u00e9moins.<\/li>\n<li>Validation internationale des domaines d\u2019\u00e9valuation des neurofibromes cutan\u00e9s dans la neurofibromatose de type 1.<\/li>\n<li>Efficacit\u00e9 pr\u00e9-clinique d\u2019un inhibiteur de MEK dans la pr\u00e9vention du d\u00e9veloppement des neurofibromes cutan\u00e9s dans la neurofibromatose de type 1.<\/li>\n<\/ul>\n<p><span style=\"text-decoration: underline;\">Laura Mengeot :<\/span><\/p>\n<ul>\n<li>Pr\u00e9valence de l\u2019ob\u00e9sit\u00e9 chez des patients adultes atteints de neurofibromatose de type 1.<\/li>\n<\/ul>\n<p><strong>3 posters seront affich\u00e9s,<\/strong> r\u00e9alis\u00e9s par Christina Bergqvist et Laura Fertitta :<\/p>\n<p><span style=\"text-decoration: underline;\">Christina Bergqvist :<\/span><\/p>\n<ul>\n<li>Caract\u00e9ristiques cliniques des neurofibromes cutan\u00e9s trait\u00e9s par laser CO2 : focus sur la visibilit\u00e9.<\/li>\n<li>\u00c9valuation de la fiabilit\u00e9 et de la maniabilit\u00e9 d\u2019un appareil photo 3D pour mesurer les neurofibromes cutan\u00e9s.<\/li>\n<\/ul>\n<p><span style=\"text-decoration: underline;\">Laura Fertitta :<\/span><\/p>\n<ul>\n<li>Rayons ultra-violets et d\u00e9veloppement des neurofibromes cutan\u00e9s li\u00e9s \u00e0 la neurofibromatose de type 1 : point de vue des patients.<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>L&rsquo;\u00e9quipe du centre CERENEF, Centre de R\u00e9f\u00e9rence des Neurofibromatoses sera pr\u00e9sente aux Journ\u00e9es Dermatologiques de Paris (JDP) 2023 qui se d\u00e9rouleront du 05 au 09 d\u00e9cembre au Palais des Congr\u00e8s de Paris ! 4 communications orales seront pr\u00e9sent\u00e9es par Laura Fertitta et Laura Mengeot lors de la session \u00ab\u00a0G\u00e9n\u00e9tique et g\u00e9nodermatoses\u00a0\u00bb, le mercredi 06 d\u00e9cembre&hellip;&nbsp;<\/p>\n<div class=\"read-more-wrapper\"><a href=\"https:\/\/cerenef.org\/en\/jdp-2023\/\" class=\"button button-secondary\" rel=\"bookmark\">\u279c Read more<span class=\"screen-reader-text\">JDP 2023<\/span><\/a><\/div>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","neve_meta_reading_time":"","footnotes":""},"categories":[8],"tags":[],"class_list":["post-3458","post","type-post","status-publish","format-standard","hentry","category-actualites"],"_links":{"self":[{"href":"https:\/\/cerenef.org\/en\/wp-json\/wp\/v2\/posts\/3458","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cerenef.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cerenef.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cerenef.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cerenef.org\/en\/wp-json\/wp\/v2\/comments?post=3458"}],"version-history":[{"count":0,"href":"https:\/\/cerenef.org\/en\/wp-json\/wp\/v2\/posts\/3458\/revisions"}],"wp:attachment":[{"href":"https:\/\/cerenef.org\/en\/wp-json\/wp\/v2\/media?parent=3458"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cerenef.org\/en\/wp-json\/wp\/v2\/categories?post=3458"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cerenef.org\/en\/wp-json\/wp\/v2\/tags?post=3458"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}